Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
This Bitcoin-focused microcap is building a treasury strategy centered on accumulating BTC (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Trevena Inc (EM) TRVN

Healthcare Biotechnology
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (EXPM:TRVN)

Trevena Reports Third Quarter 2024 Results and Provides Business Update

GlobeNewswire November 7, 2024

Trevena Announces Receipt of Nasdaq Delisting Notification

GlobeNewswire October 4, 2024

Trevena Announces Reverse Stock Split

GlobeNewswire August 8, 2024

Trevena Reports Second Quarter 2024 Results and Provides Business Update

GlobeNewswire August 8, 2024

Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors

GlobeNewswire August 1, 2024

Trevena Announces $2M Non-Dilutive Financing Tranche and Reduction in Outstanding Liabilities in Connection with Existing ex-US Royalty Financing

GlobeNewswire July 8, 2024

Trevena Announces Preclinical TRV045 Data Providing Insight Into Novel Mechanism of Analgesic Effect in Chronic Neuropathic Pain Model and Demonstrating Statistically Significant Anti-Seizure Activity in Epilepsy Models

GlobeNewswire June 20, 2024

Trevena Reports First Quarter 2024 Results and Provides Business Update

GlobeNewswire May 15, 2024

Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update

GlobeNewswire April 1, 2024
View More News ››

Opinion & Analysis (EXPM:TRVN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:TRVN)

TRVN.....get ready for the opening bell dumpfest ; )

Cheers !
Iseneschal - June 20, 2024

RE:RE:BANGARAG - OLI is FDA APPROVED!!!!!

TRVN must be HOT...The WEASEL is back WHACKIN'it!! Best GG
GolongGekko - October 7, 2020

RE:BANGARAG - OLI is FDA APPROVED!!!!!

Hey Gekko, you still livin in yer mom's basement , lol,  how ya been, happy to see your trvn finally do something for ya, ...
ferret_ca - September 25, 2020

FDA site

On FDA site as well as 'popular news' sites.  Trevena will do a press release Monday (hopefully before open) and the stock...
SandMan67 - August 8, 2020

BANGARAG - OLI is FDA APPROVED!!!!!

https://apnews.com/PR%20Newswire/9e564a43c97adf428b4d5a70478465b5 It PAYS to be A GEKKO . . . Only took 3+ years! Best to all my...
GolongGekko - August 7, 2020

FDA - Oliceridine

One more day and we find out if the FDA has approved their resubmission on their morphine alternative drug.  https://www...
SandMan67 - August 6, 2020
View more Bullboard ››

MindBio Therapeutics Corp.

MindBio Therapeutics Corp.

MindBio Therapeutics Corp., together with its subsidiaries, engages in researching, developing, and testing psychedelic ...
View More »

Podcasts